Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Basilea buoyed by sales increase

September 1, 2009 Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …
News

Supply chain controls blamed for UK medicines shortage

August 27, 2009 Manufacturing and Production, Research and Development supply chain

Industry supply chain controls in the UK have overwhelmingly made medicines more difficult to source and have put patients risk, …
News

Americans doubt benefits of health reform

August 27, 2009 Research and Development, Sales and Marketing US, US healthcare, healthcare

Most Americans are satisfied with their existing medical arrangements, according to a survey by Thomson Reuters.The results seem to be …
News

NICE criticised for rejection of kidney cancer drugs

August 27, 2009 Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …
News

Novartis unveils new lab approach to boost research capacity

August 27, 2009 Research and Development Novartis, Switzerland

Novartis has unveiled a new research approach involving novel lab technology and flexible working, in the hope to speed its …
News

More evidence of tobacco’s role as drugmaking factory

August 27, 2009 Manufacturing and Production, Research and Development Biodesign Institute

Researchers have successfully engineered tobacco to synthesise the antigens for a vaccine against norovirus, providing further evidence that complex pharmaceuticals …
News

Vasella adds voice to NHS criticism

August 27, 2009 Research and Development, Sales and Marketing NHS, healthcare

Novartis chief executive Daniel Vasella defended the industry's high cost oncology treatments, and said he would not want to be …
News

Gardasil cleared in FDA safety review

August 27, 2009 Research and Development, Sales and Marketing Gardasil, US, vaccines

News

Warner Chilcott buys P&G pharma for $3.1 billion

August 25, 2009 Research and Development, Sales and Marketing MA, P&G, Warner Chilcott

Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …
News

Pfizer to develop online community to find new trials patients

August 24, 2009 Medical Communications, Research and Development, Sales and Marketing Pfizer, digi

Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials.Pfizer has …
News

‘No shortcuts’ on H1N1 vaccine safety says GlaxoSmithKline

August 20, 2009 Research and Development, Sales and Marketing GSK, h1n1, vaccines

GlaxoSmithKline says the public need not doubt the safety of its vaccine against the H1N1 swine flu, which it is …
News

Avastin shows promise in advanced breast cancer

August 20, 2009 Research and Development, Sales and Marketing Roche, avastin, breast cancer

Avastin's rise continues as new data suggests it improves progression-free survival as a second line treatment for advanced breast cancer.The …
News

Obstacles remain for patients with blood cancers

August 20, 2009 Research and Development, Sales and Marketing NICE, blood cancer

News

Manchester research hub appoints industry liaison

August 19, 2009 Research and Development Academic, NHS

The Manchester Biomedical Research Centre (BRC) has appointed a new industry-facing executive to forge new research links with the industry.Dr …
News

Novartis’ Extavia approved in US

August 19, 2009 Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026